Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00199433 · ClinicalTrials.gov registry record · Phase 2

A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients

A Phase 2 study of Parkinson's Disease and Movement Disorder Syndrome, sponsored by Kyowa Kirin.

Completed
Registry status
Phase 2
Development phase
160
Enrollment target
1
Study location

NCT00199433 is a Phase 2 study of Parkinson's Disease and Movement Disorder Syndrome that has completed, run by Kyowa Kirin. The registered enrollment target is 160 participants, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00199433, a Phase 2 study of Parkinson's Disease and Movement Disorder Syndrome, has completed, sponsored by Kyowa Kirin.

COMPLETED
Registry status
Phase 2
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of 40 mg per day of istradefylline (KW6002) as monotherapy in patients with Parkinson's disease.

Conditions Studied

Parkinson's Disease Movement Disorder Syndrome

Interventions

  • DRUG Istradefylline (KW-6002)

Study Locations (1)

New Jersey

  • Kyowa Pharmaceutical Inc. - Princeton

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2005-05
Est. Completion 2006-08
Phase Phase 2

Sponsor

Kyowa Kirin

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00199433

The ClinicalTrials.gov registry entry for NCT00199433 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (75% lower). The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Istradefylline (KW-6002) is the first listed.

NCT00199433 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00199433 about?

NCT00199433 is a clinical study titled "A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients". The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of 40 mg per day of istradefylline (KW6002) as monotherapy in patients with Parkinson's disease.

What is the current status of trial NCT00199433?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2005-05. Estimated completion is 2006-08.

What conditions does trial NCT00199433 study?

This clinical trial studies the following conditions: Parkinson's Disease, Movement Disorder Syndrome.

What interventions are being tested in trial NCT00199433?

The interventions under investigation include: Istradefylline (KW-6002) (DRUG).

Who is sponsoring clinical trial NCT00199433?

This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00199433 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Movement Disorder Syndrome

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.